Glenmark Pharmaceuticals Limited (BOM:532296)
India · Delayed Price · Currency is INR 2,286.75
-2.20 (-0.10%)
At close: Oct 7, 2026
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 651.54 billion as of October 7, 2026. Its market cap has increased by 17.13% in one year.
Market Cap
651.54B
Enterprise Value
645.71B
Revenue
177.37B
Ranking
n/a
PE Ratio
36.27
Stock Price
2,286.75
ChartMarket Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 651.54B, an increase of 56,589.93%. That is a compound annual growth rate of 28.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 651.54B | 13.44% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zydus Lifesciences | 1.16T |
| Laurus Labs | 1.11T |
| Cipla | 1.08T |
| Mankind Pharma | 1.03T |
| Aurobindo Pharma | 974.00B |
| Glenmark Pharmaceuticals | 652.17B |
| Alkem Laboratories | 632.74B |
| Gland Pharma | 495.91B |